Jun. 18 at 1:24 PM
$IPIX Thanks to @fit007 for sharing multiple papers about Brilacidin with different companies - Gilead, Topella, Ascent pharma.
I wonder if the end game will be multiple licensing deals with streams of royalties in play or would it be a full acquisition by one of the interested parties?
Any thoughts other than the usual - BK😀